Company profile for TELA Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

TELA Bio is a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials that are purposefully designed to address the unmet needs in soft tissue reconstruction. Our seasoned leadership team dedicates their expertise in medical technology to improve outcomes in soft tissue reconstruction procedures and make natural repair solutions more accessible...
TELA Bio is a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials that are purposefully designed to address the unmet needs in soft tissue reconstruction. Our seasoned leadership team dedicates their expertise in medical technology to improve outcomes in soft tissue reconstruction procedures and make natural repair solutions more accessible to patients. At TELA Bio, we believe that genuine collaboration with surgeons and healthcare providers results in the development of solutions that improve clinical outcomes and empower patient care.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Great Valley Parkway, Suite 24 Malvern, PA 19355
Telephone
Telephone
(484) 320-2930
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/12/3204862/0/en/TELA-Bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
12 Dec 2025

https://www.globenewswire.com/news-release/2025/11/19/3190923/0/en/TELA-Bio-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

GLOBENEWSWIRE
19 Nov 2025

https://www.globenewswire.com/news-release/2025/11/17/3189577/0/en/TELA-Bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187881/0/en/TELA-Bio-Announces-Pricing-of-13-0-Million-Underwritten-Registered-Direct-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187804/0/en/TELA-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Refinancing-and-Upsizing-of-Credit-Facility.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180338/0/en/TELA-Bio-to-Announce-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
04 Nov 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty